Preventable diseases could gain a foothold because of COVID-19March 23, 2020Business of MedicinePediatrics
2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineMixed TopicsLymphoma & Plasma Cell DisordersRare Diseases
Biosimilars poised to save $54 billion over the next decadeOctober 25, 2017Business of MedicineGastroenterology
Emergency department use by recently diagnosed cancer patients in CaliforniaMay 17, 2017Patient & Survivor CareBusiness of Medicine
Repeal and replace? How about retain, review, and refine?May 17, 2017Patient & Survivor CareBusiness of Medicine
Clinical, practice, and policy trends: a round-up and review of the 2016 oncology landscapeDecember 22, 2016Business of Medicine
Value-based cancer care and the patient perspectiveNovember 22, 2016Patient & Survivor CareBusiness of Medicine
Deconstructing MACRA: the switch from volume- to value-based paymentSeptember 30, 2016Patient & Survivor CareBusiness of Medicine
